Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Northbound Flows: Mindray, Tianjin Zhonghuan, BYD, Banks

Northbound Flows: Yunnan Energy New Material, Zhejiang Huayou Cobalt, BOE Technology

Northbound Flows: Huayou Cobalt, CMB, Zhongtian Tech, TCL

Northbound Flows: Moutai, East Money, Ping An Insurance, Wuxi Apptec, BYD

Northbound Flows: Moutai, East Money, Gree, Wuxi Apptec, Tongwei

Northbound Flows: $5.7bn Inflows, Biggest Since Dec

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>We analyze the weekly Shanghai/Shenzhen northbound Connect flows with our data engine.</li>
<li>Inflows into the consumer staple and health care were offset by the outflows from industrials and material sector.</li>
<li>We highlight inflows into the Tianqi Lithium-A prior to its H-share debut next week.</li>
</ul>


We analyze the weekly Shanghai/Shenzhen northbound Connect flows with our data engine.
Inflows into the consumer staple and health care were offset by the outflows from industrials and material sector.
We highlight inflows into the Tianqi Lithium-A prior to its H-share debut next week.


China Tourism Group Duty Free Corp Ltd (601888 CH)

Contemporary Amperex Technology (CATL) (300750 CH)

Northbound Flows: Tianqi Lithium Inflow Before H-Share Listing